Barbara Duncan
2015
In 2015, Barbara Duncan earned a total compensation of $2.2M as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, a 68% increase compared to previous year.
Compensation breakdown
| Bonus | $166,000 |
|---|---|
| Option Awards | $933,680 |
| Salary | $415,000 |
| Stock Awards | $619,196 |
| Other | $21,168 |
| Total | $2,155,044 |
Duncan received $933.7K in option awards, accounting for 43% of the total pay in 2015.
Duncan also received $166K in bonus, $415K in salary, $619.2K in stock awards and $21.2K in other compensation.
Rankings
In 2015, Barbara Duncan's compensation ranked 4,425th out of 13,638 executives tracked by ExecPay. In other words, Duncan earned more than 67.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,425 out of 13,638 | 68th |
Division Manufacturing | 1,613 out of 5,187 | 69th |
Major group Chemicals And Allied Products | 584 out of 1,857 | 69th |
Industry group Drugs | 463 out of 1,531 | 70th |
Industry Pharmaceutical Preparations | 365 out of 1,179 | 69th |
Source: SEC filing on June 20, 2016.
Duncan's colleagues
We found five more compensation records of executives who worked with Barbara Duncan at Intercept Pharmaceuticals in 2015.
2015
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2015
Lisa Bright
Intercept Pharmaceuticals
Chief Commercial and Corporate Affairs Officer
2015
David Shapiro
Intercept Pharmaceuticals
Chief Medical Officer
2015
Rachel McMinn
Intercept Pharmaceuticals
Chief Strategy and Business Officer
2015
Daniel Regan
Intercept Pharmaceuticals